Andreas Rummelt, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 10,000 shares at $107.00 ($1.1M) on 2012-07-27, disclosed to the SEC on 2012-07-31.
Open-market sale of $1.1M ALXN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ALXN | SELL | 2012-02-23 | $537K | — | Filing → |
| ALXN | SELL | 2011-10-25 | $622K | — | Filing → |
| ALXN | BUY | 2010-05-12 | $263K | — | Filing → |